A Case of atypical Femoral Fracture after Dosing Denosumab

For the management of patients with castration-resistant prostate cancer with bone metastases, bisphosphonates and denosumab are used to prevent skeletal related events. Osteonecrosis of the jaw and hypocalcemia have been reported in patients treated with denosumab, but there have been few reports o...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 66(2020), 1 vom: 03. Jan., Seite 23-27
1. Verfasser: Takahashi, Toshifumi (VerfasserIn)
Weitere Verfasser: Ito, Katsuhiro, Kanno, Toru, Okada, Takashi, Higashi, Yoshihito, Yamada, Hitoshi
Format: Online-Aufsatz
Sprache:Japanese
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Case Reports Journal Article Bone Density Conservation Agents Diphosphonates Denosumab 4EQZ6YO2HI